Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02087852 · ClinicalTrials.gov registry record
Kidney Cancer DNA Registry
A clinical trial of Renal Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 750
- Enrollment target
- 7
- Study locations
NCT02087852 is a study of Renal Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 750 participants, above the 584-participant average among 29 other Renal Cancer trials with a reported enrollment target (28% higher). The trial reports 7 study locations across 2 states.
The verdict
NCT02087852, a study of Renal Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 750 participants
- Enrollment target
- 7
- Study locations
Study Summary
This registry will help us develop better methods of: * Preventing these cancers * Diagnosing these cancers * Treating these cancers
Conditions Studied
Interventions
- OTHER Blood draw
- OTHER salvia for germline DNA
- BEHAVIORAL the Kidney Cancer Questionnaire
- BEHAVIORAL Family History Questionnaire (when applicable)
- BEHAVIORAL Epidemiologic Questionnaire
Study Locations (7)
New York
- Memorial Sloan Kettering Commack (Consent and Follow-up) - Commack
- Memorial Sloan Kettering Westchester (Consent and Follow up) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (Consent and Follow-Up) - Uniondale
New Jersey
- Memorial Sloan Kettering at Basking Ridge (Consent and Follow-up) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent and Follow up) - Middletown
- Memorial Sloan Kettering Bergen (Consent and Follow up ) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2014-03 |
| Est. Completion | 2026-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02087852
The ClinicalTrials.gov registry entry for NCT02087852 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 584-participant average among 29 other Renal Cancer trials with a reported enrollment target (28% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Renal Cancer appearing as the primary indexed condition, and to 5 interventions - of which Blood draw is the first listed.
NCT02087852 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02087852 about?
NCT02087852 is a clinical study titled "Kidney Cancer DNA Registry". This registry will help us develop better methods of: * Preventing these cancers * Diagnosing these cancers * Treating these cancers
What is the current status of trial NCT02087852?
This trial is currently recruiting. The enrollment target is 750 participants. The study started on 2014-03. Estimated completion is 2026-03.
What conditions does trial NCT02087852 study?
This clinical trial studies the following conditions: Renal Cancer.
What interventions are being tested in trial NCT02087852?
The interventions under investigation include: Blood draw (OTHER), salvia for germline DNA (OTHER), the Kidney Cancer Questionnaire (BEHAVIORAL), Family History Questionnaire (when applicable) (BEHAVIORAL), Epidemiologic Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02087852?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02087852 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RECRUITING
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
RECRUITING · Phase 1
-
Advanced Diffusion Imaging in Renal Cancer Patients
RECRUITING · NA
-
A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.